Indeed, despite the decreased MK activities, MKD patients can still generate sufficient isoprenoid end products under normal circumstances, due to an increased activity of HMGR in patients’ cells which compensates for the decreased flux of the isoprenoid biosynthesis pathway. This evidence concerns the gene HMGA1 and mevalonic aciduria.